Embryonic Stem Cells

Embryonic stem cells are pluripotent and can in principle form any cell type. Their clinical use is tightly regulated and protocol-specific.

How Embryonic Stem Cells are used

The therapeutic value of Embryonic Stem Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Embryonic Stem Cells feature

Quality & safety

• GMP-certified preparation in the European Union
• Characterised, viability-tested cells from a certified bank
• Personalised dosing within a physician-led protocol
• Transparent pricing — €3,000–€8,000 per programme

Educational information. Embryonic Stem Cells protocols for several conditions remain investigational; outcomes vary by patient.